Ropharma SA (RPH) Stock Price, Fundamentals & Analysis

What RPH does

Ropharma SA (RPH) operates a chain of pharmacies in Romania, offering prescription and over-the-counter medicines, food supplements, dermato-cosmetics, cosmetics, and medical devices. The company also provides medical services in areas such as oncology, hematology, bariatric surgery, and robotic surgery, and runs a renal transplant and cardiovascular disease center. Incorporated in 1952 and headquartered in Brasov, Romania, Ropharma is part of the Pharmaceutical Retailers peer group on the Bucharest Stock Exchange (BVB), alongside companies like Antibiotice S.A. (ATB) and Biofarm S.A. (BIO).

Key numbers explained

• 0.21 RON is the current share price, representing the latest trading value of one RPH share.
• +0.97% is today's price change, showing the percentage move relative to the previous close.
• 106.34M RON is the market capitalisation, calculated as the share price multiplied by the total number of shares outstanding.
• The trailing P/E ratio of 10.8 divides the share price by the last 12 months' earnings per share; a lower figure can suggest the stock is priced conservatively relative to earnings.
• The dividend yield is 0%, meaning the company currently pays no cash dividend to shareholders.
• 0.33 is the beta, indicating RPH's share price has historically moved about one-third as much as the overall market.
• 0.41 is the price-to-book ratio, comparing the share price to the company's book value per share; a figure below 1 can suggest the market values the company below its accounting net assets.
• 19.7% revenue growth year over year shows the trailing 12-month top-line expansion compared with the same period a year earlier.

Recent news

Recent disclosures include the announcement of the AGAE meeting on 20.10.2026, the publication of the S1 2026 semi-annual report, and the O&E AGA decisions dated 29.05.2026. The company also released its Q1 2026 quarterly report and disclosed a modification to its 2026 financial calendar.

What to watch

Investors tracking Ropharma SA (RPH) typically monitor pharmacy-sector dynamics, including changes in drug pricing regulation and reimbursement policies in Romania. The company's mix of retail pharmacy operations and medical services means it can be sensitive to healthcare spending trends and hospital activity levels. Broader factors such as interest-rate movements, which affect discount rates used in valuation, and the competitive landscape with peers like Farmaceutica Remedia SA (RMAH) are also relevant.